Results
|
10181.
|
|
|
10182.
|
Cisplatin plus weekly CPT-11/docetaxel in advanced esophagogastric cancer: a phase I study with pharmacogenetic assessment of XPD, XRCC3 and UGT1A1 polymorphisms. [electronic resource] by
- Font, Albert
- Salazar, Ramon
- Maurel, Joan
- Taron, Miquel
- Ramirez, Jose Luis
- Tabernero, Josep
- Gallego, Rosa
- Casado, Esther
- Manzano, Jose Luis
- Carcereny, Enric
- Guix, Marta
- Fernández-Llamazares, Jaume
- Rosell, Rafael
Producer: 20081216
In:
Cancer chemotherapy and pharmacology vol. 62
Availability: No items available.
|
|
10183.
|
Antiproliferative effects of sapacitabine (CYC682), a novel 2'-deoxycytidine-derivative, in human cancer cells. [electronic resource] by
- Serova, M
- Galmarini, C M
- Ghoul, A
- Benhadji, K
- Green, S R
- Chiao, J
- Faivre, S
- Cvitkovic, E
- Le Tourneau, C
- Calvo, F
- Raymond, E
Producer: 20071009
In:
British journal of cancer vol. 97
Availability: No items available.
|
|
10184.
|
|
|
10185.
|
|
|
10186.
|
|
|
10187.
|
Phase 2 study of neoadjuvant treatment with NOV-002 in combination with doxorubicin and cyclophosphamide followed by docetaxel in patients with HER-2 negative clinical stage II-IIIc breast cancer. [electronic resource] by
- Montero, A J
- Diaz-Montero, C M
- Deutsch, Y E
- Hurley, J
- Koniaris, L G
- Rumboldt, T
- Yasir, S
- Jorda, M
- Garret-Mayer, E
- Avisar, E
- Slingerland, J
- Silva, O
- Welsh, C
- Schuhwerk, K
- Seo, P
- Pegram, M D
- Glück, S
Producer: 20120522
In:
Breast cancer research and treatment vol. 132
Availability: No items available.
|
|
10188.
|
Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial. [electronic resource] by
- Gianni, Luca
- Pienkowski, Tadeusz
- Im, Young-Hyuck
- Roman, Laslo
- Tseng, Ling-Ming
- Liu, Mei-Ching
- Lluch, Ana
- Staroslawska, Elżbieta
- de la Haba-Rodriguez, Juan
- Im, Seock-Ah
- Pedrini, Jose Luiz
- Poirier, Brigitte
- Morandi, Paolo
- Semiglazov, Vladimir
- Srimuninnimit, Vichien
- Bianchi, Giulia
- Szado, Tania
- Ratnayake, Jayantha
- Ross, Graham
- Valagussa, Pinuccia
Producer: 20120221
In:
The Lancet. Oncology vol. 13
Availability: No items available.
|
|
10189.
|
Serum biomarkers as potential predictors of antitumor activity of cetuximab-containing therapy for locally advanced head and neck cancer. [electronic resource] by
- Argiris, Athanassios
- Lee, Steve C
- Feinstein, Trevor
- Thomas, Sufi
- Branstetter, Barton F
- Seethala, Raja
- Wang, Lin
- Gooding, William
- Grandis, Jennifer R
- Ferris, Robert L
Producer: 20120120
In:
Oral oncology vol. 47
Availability: No items available.
|
|
10190.
|
A small-molecule inhibitor targeting the mitotic spindle checkpoint impairs the growth of uterine leiomyosarcoma. [electronic resource] by
- Shan, Weiwei
- Akinfenwa, Patricia Y
- Savannah, Kari B
- Kolomeyevskaya, Nonna
- Laucirica, Rudolfo
- Thomas, Dafydd G
- Odunsi, Kunle
- Creighton, Chad J
- Lev, Dina C
- Anderson, Matthew L
Producer: 20121220
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 18
Availability: No items available.
|
|
10191.
|
|
|
10192.
|
Differential effect of adjuvant taxane-based and taxane-free chemotherapy regimens on the CK-19 mRNA-positive circulating tumour cells in patients with early breast cancer. [electronic resource] by
- Xenidis, N
- Perraki, M
- Apostolaki, S
- Agelaki, S
- Kalbakis, K
- Vardakis, N
- Kalykaki, A
- Xyrafas, A
- Kakolyris, S
- Mavroudis, D
- Georgoulias, V
Producer: 20130423
In:
British journal of cancer vol. 108
Availability: No items available.
|
|
10193.
|
SERPINA6, BEX1, AGTR1, SLC26A3, and LAPTM4B are markers of resistance to neoadjuvant chemotherapy in HER2-negative breast cancer. [electronic resource] by
- de Ronde, Jorma J
- Lips, Esther H
- Mulder, Lennart
- Vincent, Andrew D
- Wesseling, Jelle
- Nieuwland, Marja
- Kerkhoven, Ron
- Vrancken Peeters, Marie-Jeanne T F D
- Sonke, Gabe S
- Rodenhuis, Sjoerd
- Wessels, Lodewyk F A
Producer: 20130527
In:
Breast cancer research and treatment vol. 137
Availability: No items available.
|
|
10194.
|
|
|
10195.
|
The significance of TNFAIP8 in prostate cancer response to radiation and docetaxel and disease recurrence. [electronic resource] by
- Zhang, Chuanbo
- Kallakury, Bhaskar V
- Ross, Jeffrey S
- Mewani, Rajshree R
- Sheehan, Christine E
- Sakabe, Isamu
- Luta, George
- Kumar, Deepak
- Yadavalli, Sivaramakrishna
- Starr, Joshua
- Sreenath, Taduru L
- Srivastava, Shiv
- Pollard, Harvey B
- Eidelman, Ofer
- Srivastava, Meera
- Kasid, Usha N
Producer: 20130611
In:
International journal of cancer vol. 133
Availability: No items available.
|
|
10196.
|
|
|
10197.
|
A phase II study of neoadjuvant and adjuvant chemotherapy with 5-fluorodeoxyuridine, leucovorin, oxaliplatin and docetaxel in the treatment of previously untreated advanced esophageal adenocarcinoma. [electronic resource] by
- Solomon, Naveenraj
- Mezentsev, Dmitry
- Reis, Isildinha
- Lima, Myra
- Rios, Joyce
- Avisar, Eli
- Franceschi, Dido
- Livingstone, Alan
- Podolsky, Lisa
- Ardalan, Bach
Producer: 20110523
In:
Japanese journal of clinical oncology vol. 41
Availability: No items available.
|
|
10198.
|
|
|
10199.
|
Sabutoclax, a Mcl-1 antagonist, inhibits tumorigenesis in transgenic mouse and human xenograft models of prostate cancer. [electronic resource] by
- Jackson, Roger S
- Placzek, William
- Fernandez, Ana
- Ziaee, Shabnam
- Chu, Chia-Yi
- Wei, Jun
- Stebbins, John
- Kitada, Shinichi
- Fritz, Gloria
- Reed, John C
- Chung, Leland W
- Pellecchia, Maurizio
- Bhowmick, Neil A
Producer: 20130318
In:
Neoplasia (New York, N.Y.) vol. 14
Availability: No items available.
|
|
10200.
|
|